Johnson & Johnson EBITDA Margin 1986-2025 | JNJ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Johnson & Johnson (JNJ) over the last 10 years. The current EBITDA margin for Johnson & Johnson as of June 30, 2025 is .
| Johnson & Johnson EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-06-30 |
$90.63B |
$36.81B |
40.62% |
| 2025-03-31 |
$89.33B |
$36.00B |
40.30% |
| 2024-12-31 |
$88.82B |
$26.11B |
29.40% |
| 2024-09-30 |
$87.70B |
$27.10B |
30.90% |
| 2024-06-30 |
$86.58B |
$29.04B |
33.54% |
| 2024-03-31 |
$85.65B |
$29.63B |
34.59% |
| 2023-12-31 |
$85.16B |
$24.58B |
28.86% |
| 2023-09-30 |
$76.31B |
$22.09B |
28.94% |
| 2023-06-30 |
$74.96B |
$21.53B |
28.73% |
| 2023-03-31 |
$77.46B |
$20.44B |
26.38% |
| 2022-12-31 |
$79.99B |
$27.10B |
33.87% |
| 2022-09-30 |
$77.21B |
$25.56B |
33.11% |
| 2022-06-30 |
$80.55B |
$24.20B |
30.04% |
| 2022-03-31 |
$79.85B |
$25.07B |
31.39% |
| 2021-12-31 |
$78.74B |
$26.80B |
34.04% |
| 2021-09-30 |
$91.45B |
$27.34B |
29.89% |
| 2021-06-30 |
$89.19B |
$27.92B |
31.30% |
| 2021-03-31 |
$84.21B |
$25.09B |
29.80% |
| 2020-12-31 |
$82.58B |
$24.04B |
29.11% |
| 2020-09-30 |
$80.86B |
$26.55B |
32.84% |
| 2020-06-30 |
$80.50B |
$23.79B |
29.55% |
| 2020-03-31 |
$82.73B |
$26.98B |
32.61% |
| 2019-12-31 |
$82.06B |
$25.01B |
30.48% |
| 2019-09-30 |
$81.71B |
$24.12B |
29.51% |
| 2019-06-30 |
$81.33B |
$27.18B |
33.42% |
| 2019-03-31 |
$81.59B |
$25.33B |
31.04% |
| 2018-12-31 |
$81.58B |
$26.54B |
32.54% |
| 2018-09-30 |
$81.38B |
$26.03B |
31.98% |
| 2018-06-30 |
$80.68B |
$26.26B |
32.55% |
| 2018-03-31 |
$78.69B |
$25.42B |
32.31% |
| 2017-12-31 |
$76.45B |
$24.63B |
32.22% |
| 2017-09-30 |
$74.36B |
$25.51B |
34.30% |
| 2017-06-30 |
$72.53B |
$25.18B |
34.72% |
| 2017-03-31 |
$72.17B |
$25.04B |
34.69% |
| 2016-12-31 |
$71.89B |
$24.65B |
34.29% |
| 2016-09-30 |
$71.60B |
$23.99B |
33.51% |
| 2016-06-30 |
$70.88B |
$22.72B |
32.06% |
| 2016-03-31 |
$70.18B |
$23.42B |
33.37% |
| 2015-12-31 |
$70.07B |
$23.62B |
33.71% |
| 2015-09-30 |
$70.52B |
$22.47B |
31.86% |
| 2015-06-30 |
$71.88B |
$25.16B |
35.00% |
| 2015-03-31 |
$73.59B |
$25.09B |
34.10% |
| 2014-12-31 |
$74.33B |
$25.06B |
33.71% |
| 2014-09-30 |
$74.43B |
$25.21B |
33.87% |
| 2014-06-30 |
$73.54B |
$22.08B |
30.03% |
| 2014-03-31 |
$71.92B |
$21.28B |
29.59% |
| 2013-12-31 |
$71.31B |
$20.13B |
28.23% |
| 2013-09-30 |
$70.52B |
$20.39B |
28.91% |
| 2013-06-30 |
$69.99B |
$20.37B |
29.11% |
| 2013-03-31 |
$68.59B |
$17.50B |
25.51% |
| 2012-12-31 |
$67.22B |
$18.04B |
26.83% |
| 2012-09-30 |
$65.92B |
$15.16B |
22.99% |
| 2012-06-30 |
$64.87B |
$15.45B |
23.82% |
| 2012-03-31 |
$65.00B |
$16.75B |
25.77% |
| 2011-12-31 |
$65.03B |
$16.18B |
24.88% |
| 2011-09-30 |
$64.42B |
$17.96B |
27.88% |
| 2011-06-30 |
$63.40B |
$17.98B |
28.36% |
| 2011-03-31 |
$62.13B |
$18.71B |
30.11% |
| 2010-12-31 |
$61.59B |
$20.45B |
33.20% |
| 2010-09-30 |
$62.49B |
$20.74B |
33.19% |
| 2010-06-30 |
$62.59B |
$20.77B |
33.18% |
| 2010-03-31 |
$62.50B |
$20.77B |
33.23% |
| 2009-12-31 |
$61.90B |
$19.07B |
30.81% |
| 2009-09-30 |
$60.53B |
$20.05B |
33.13% |
| 2009-06-30 |
$61.37B |
$20.24B |
32.98% |
| 2009-03-31 |
$62.58B |
$20.41B |
32.62% |
| 2008-12-31 |
$63.75B |
$20.56B |
32.25% |
| 2008-09-30 |
$64.52B |
$19.55B |
30.30% |
| 2008-06-30 |
$63.57B |
$18.35B |
28.87% |
| 2008-03-31 |
$62.25B |
$17.97B |
28.87% |
| 2007-12-31 |
$61.10B |
$16.81B |
27.51% |
| 2007-09-30 |
$58.82B |
$16.90B |
28.72% |
| 2007-06-30 |
$57.14B |
$17.24B |
30.16% |
| 2007-03-31 |
$55.37B |
$16.74B |
30.23% |
| 2006-12-31 |
$53.32B |
$17.66B |
33.11% |
| 2006-09-30 |
$52.25B |
$17.32B |
33.15% |
| 2006-06-30 |
$51.28B |
$16.99B |
33.14% |
| 2006-03-31 |
$50.67B |
$16.56B |
32.68% |
| 2005-12-31 |
$50.51B |
$15.75B |
31.18% |
| 2005-09-30 |
$50.66B |
$15.44B |
30.47% |
| 2005-06-30 |
$49.90B |
$15.18B |
30.42% |
| 2005-03-31 |
$48.62B |
$15.29B |
31.44% |
| 2004-12-31 |
$47.35B |
$14.84B |
31.34% |
| 2004-09-30 |
$45.85B |
$14.94B |
32.59% |
| 2004-06-30 |
$44.75B |
$14.68B |
32.79% |
| 2004-03-31 |
$43.60B |
$13.20B |
30.28% |
| 2003-12-31 |
$41.86B |
$12.56B |
30.01% |
| 2003-09-30 |
$40.01B |
$11.92B |
29.80% |
| 2003-06-30 |
$38.64B |
$11.28B |
29.20% |
| 2003-03-31 |
$37.38B |
$11.68B |
31.24% |
| 2002-12-31 |
$36.30B |
$11.37B |
31.32% |
| 2002-09-30 |
$35.12B |
$10.98B |
31.26% |
| 2002-06-30 |
$34.10B |
$10.74B |
31.51% |
| 2002-03-31 |
$33.21B |
$10.47B |
31.53% |
| 2001-12-31 |
$32.32B |
$10.11B |
31.29% |
| 2001-09-30 |
$31.20B |
$9.79B |
31.38% |
| 2001-06-30 |
$30.58B |
$9.51B |
31.10% |
| 2001-03-31 |
$30.07B |
$9.28B |
30.84% |
| 2000-12-31 |
$29.54B |
$8.93B |
30.25% |
| 2000-09-30 |
$29.30B |
$8.38B |
28.60% |
| 2000-06-30 |
$28.75B |
$8.02B |
27.91% |
| 2000-03-31 |
$28.05B |
$7.65B |
27.26% |
| 1999-12-31 |
$27.47B |
$7.37B |
26.83% |
| 1999-09-30 |
$27.06B |
$7.68B |
28.37% |
| 1999-06-30 |
$25.99B |
$7.31B |
28.13% |
| 1999-03-31 |
$24.89B |
$6.98B |
28.02% |
| 1998-12-31 |
$24.00B |
$6.57B |
27.38% |
| 1998-09-30 |
$23.16B |
$6.23B |
26.89% |
| 1998-06-30 |
$22.93B |
$6.03B |
26.31% |
| 1998-03-31 |
$22.75B |
$5.85B |
25.69% |
| 1997-12-31 |
$22.63B |
$5.69B |
25.14% |
| 1997-09-30 |
$22.50B |
$9.80B |
43.55% |
| 1997-06-30 |
$22.32B |
$9.76B |
43.73% |
| 1997-03-31 |
$22.00B |
$5.48B |
24.93% |
| 1996-12-31 |
$21.62B |
$5.31B |
24.57% |
| 1996-09-30 |
$20.96B |
$0.79B |
3.79% |
| 1996-06-30 |
$20.30B |
$0.29B |
1.41% |
| 1996-03-31 |
$19.68B |
$3.97B |
20.17% |
| 1995-12-31 |
$18.84B |
$3.51B |
18.63% |
| 1995-09-30 |
$18.09B |
$3.43B |
18.99% |
| 1995-06-30 |
$17.39B |
$3.25B |
18.68% |
| 1995-03-31 |
$16.54B |
$3.04B |
18.40% |
| 1994-12-31 |
$14.97B |
$2.05B |
13.66% |
| 1994-09-30 |
$14.41B |
$1.94B |
13.43% |
| 1994-06-30 |
$13.88B |
$1.78B |
12.79% |
| 1994-03-31 |
$13.51B |
$1.69B |
12.53% |
| 1993-12-31 |
$14.14B |
$2.39B |
16.93% |
| 1993-09-30 |
$14.11B |
$2.35B |
16.63% |
| 1993-06-30 |
$14.08B |
$2.34B |
16.63% |
| 1993-03-31 |
$13.96B |
$2.32B |
16.65% |
| 1992-12-31 |
$13.75B |
$2.28B |
16.56% |
| 1992-09-30 |
$13.40B |
$2.31B |
17.20% |
| 1992-06-30 |
$13.04B |
$2.24B |
17.18% |
| 1992-03-31 |
$12.66B |
$2.18B |
17.19% |
| 1991-12-31 |
$12.45B |
$2.16B |
17.39% |
| 1991-09-30 |
$12.00B |
$2.08B |
17.30% |
| 1991-06-30 |
$11.75B |
$2.03B |
17.28% |
| 1991-03-31 |
$11.54B |
$1.96B |
16.96% |
| 1990-12-31 |
$11.23B |
$1.99B |
17.74% |
| 1990-09-30 |
$11.00B |
$1.98B |
17.97% |
| 1990-06-30 |
$10.59B |
$1.92B |
18.18% |
| 1990-03-31 |
$10.15B |
$1.85B |
18.18% |
| 1989-12-31 |
$9.76B |
$1.66B |
17.02% |
| 1989-09-30 |
$9.49B |
$1.56B |
16.49% |
| 1989-06-30 |
$9.23B |
$1.49B |
16.10% |
| 1989-03-31 |
$9.13B |
$1.46B |
15.93% |
| 1988-12-31 |
$9.00B |
$1.40B |
15.60% |
| 1988-09-30 |
$8.73B |
$1.30B |
14.89% |
| 1988-06-30 |
$8.57B |
$1.30B |
15.18% |
| 1988-03-31 |
$8.34B |
$1.30B |
15.60% |
| 1987-12-31 |
$8.01B |
$1.21B |
15.09% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
